Topical Antibacterial Agents for Prevention of COVID-19

PHASE1CompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

September 22, 2023

Study Completion Date

September 22, 2023

Conditions
COVID-19SARS-CoV2 Infection
Interventions
DRUG

Neosporin

Neosporin is neomycin, bacitracin and polymyxin B with formulation 3.5mg/400 units/5,000 units. The subject will self-apply a small amount (approximately 0.5 g) of the ointment topically into each nostril (intranasal) twice daily (morning and evening) for seven days. Subjects are to pinch the nose to spread the cream.

OTHER

Vaseline

The subject will self-apply a small amount (approximately 0.5 g) of the ointment topically into each nostril (intranasal) twice daily (morning and evening) for seven days. Subjects are to pinch the nose to spread the cream.

Trial Locations (1)

06520

Yale University, New Haven

All Listed Sponsors
collaborator

Bill and Melinda Gates Foundation

OTHER

lead

Yale University

OTHER